StockGlow

Cytokinetics, Incorporated (KK3A.F)

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.

69.26-0.01%Healthcare
Compare KK3A.F with
StockGlow Score
92
Bullish
BearishBullish
1 year ago+112.5%

The outlook

Cytokinetics, Incorporated currently reads as bullish based on above its 50- & 200-day averages, 87% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range87% of the way from its 52-week low to high
Market cap
$9.40B
52-wk high
75.62
52-wk low
28.40
50-day avg
67.85
200-day avg
58.12
Trailing P/E
—

Similar stocks

DR6.FACADIA Pharmaceuticals Inc.$23.02+0.61%2L9.FVisionWave Holdings, Inc.$1.63-3.66%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%IM8N.FInsmed Incorporated$88.57-2.19%NKB2.FTG Therapeutics, Inc.$46.00-0.43%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy